245
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Expression Characteristics and Significant Diagnostic and Prognostic Values of ANLN in Human Cancers

, , , , ORCID Icon, ORCID Icon, , , , , ORCID Icon, ORCID Icon, , , , , , ORCID Icon, , & ORCID Icon show all
Pages 1957-1972 | Published online: 23 Feb 2022

References

  • Hausman DM. What is cancer? Perspect Biol Med. 2019;62(4):778–784. doi:10.1353/pbm.2019.0046
  • Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1459–1544.
  • Hanahan D. Rethinking the war on cancer. The Lancet. 2014;383(9916):558–563.
  • Field CM, Alberts BM. Anillin, a contractile ring protein that cycles from the nucleus to the cell cortex. J Cell Biol. 1995;131(1):165–178.
  • Hickson GR, O’Farrell PH. Anillin: a pivotal organizer of the cytokinetic machinery. Biochem Soc Trans. 2008;36(3):439–441.
  • Gbadegesin RA, Hall G, Adeyemo A, et al. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS. J Am Soc Nephrol. 2014;25(9):1991–2002.
  • Hall PA, Todd CB, Hyland PL, et al. The septin-binding protein anillin is overexpressed in diverse human tumors. Clin Cancer Res. 2005;11(19):6780–6786.
  • Xia L, Su X, Shen J, et al. ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis. Cancer Manag Res. 2018;10:663.
  • Zhang M, Wang F, Xiang Z, Huang T, Zhou WB. LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR‐200c‐3p to upregulate ANLN. Clin Exp Pharmacol Physiol. 2020;47(8):1464–1472.
  • Dai X, Mei Y, Chen X, Cai D. ANLN and KDR are jointly prognostic of breast cancer survival and can be modulated for triple negative breast cancer control. Front Genet. 2019;10:790.
  • Piekny AJ, Maddox AS The myriad roles of Anillin during cytokinesis. Paper presented at: Seminars in cell & developmental biology, 2010.
  • Olakowski M, Tyszkiewicz T, Jarzab M, et al. NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma. Folia Histochemica Et Cytobiologica. 2009;47(2):249–255.
  • Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, N Y). 2017;19(8):649–658.
  • Maciejczyk A, Szelachowska J, Czapiga B, et al. Elevated BUBR1 expression is associated with poor survival in early breast cancer patients: 15-year follow-up analysis. j Histochem Cytochem. 2013;61(5):330–339.
  • Bartha Á, Győrffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22:5.
  • Park S-J, Yoon B-H, Kim S-K, Kim S-Y. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics. 2019;12(5):101.
  • Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110.
  • Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102.
  • Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 2018;27(1):233–244.
  • Koch A, De Meyer T, Jeschke J, Van Criekinge W. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics. 2015;16(1):636.
  • Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404.
  • von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31(1):258–261.
  • Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
  • Huang DW, Sherman BT, Tan Q, et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8(9):R183–R183.
  • Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514.
  • Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–W97.
  • Á N, Győrffy B. muTarget: a platform linking gene expression changes and mutation status in solid tumors. Int j Cancer. 2021;148(2):502–511.
  • Mattingly CJ, Colby GT, Forrest JN, Boyer JL. The Comparative Toxicogenomics Database (CTD). Environ Health Perspect. 2003;111(6):793–795.
  • Luczak MW, Jagodziński PP. The role of DNA methylation in cancer development. Folia Histochemica Et Cytobiologica. 2006;44(3):143–154.
  • Ziai J, Gilbert HN, Foreman O, et al. CD8+ T cell infiltration in breast and colon cancer: a histologic and statistical analysis. PLoS One. 2018;13(1):e0190158.
  • Berger AC, Korkut A, Kanchi RS, et al. A comprehensive pan-cancer molecular study of gynecologic and breast cancers. Cancer Cell. 2018;33(4):690–705.e699.
  • Song J, Ye A, Jiang E, et al. Reconstruction and analysis of the aberrant lncRNA‐miRNA‐mRNA network based on competitive endogenous RNA in CESC. J Cell Biochem. 2018;119(8):6665–6673.
  • Zhou W, Wu J, Liu X, et al. Identification of crucial genes correlated with esophageal cancer by integrated high-throughput data analysis. Medicine. 2020;99:20.
  • Jiang P, He S, Li Y, Xu Z. Identification of therapeutic and prognostic biomarkers of Lamin C (LAMC) family members in head and neck squamous cell carcinoma. Med Sci Monitor. 2020;26:e925735–e925735.
  • Huang M, Zhang T, Yao Z-Y, et al. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma. BMC Med Genomics. 2021;14(1):72.
  • Waheed S, Zeng L. The critical role of miRNAs in regulation of flowering time and flower development. Genes (Basel). 2020;11(3):319.
  • Martinez NJ, Walhout AJM. The interplay between transcription factors and microRNAs in genome-scale regulatory networks. Bioessays. 2009;31(4):435–445.
  • Riazi Rad F, Ajdary S, Omranipour R, Alimohammadian MH, Hassan ZM. Comparative analysis of CD4+ and CD8+ T cells in tumor tissues, lymph nodes and the peripheral blood from patients with breast cancer. Iran Biomed J. 2015;19(1):35–44.
  • Győrffy B, Hatzis C, Sanft T, Hofstatter E, Aktas B, Pusztai L. Multigene prognostic tests in breast cancer: past, present, future. Breast Cancer Res. 2015;17(1):1–7.